TNO and FAST (Financiering en Acceleratie voor Therapieontwikkeling) have launched a strategic collaboration to accelerate the development of advanced therapies, including ATMPs, radiopharmaceuticals, treatments for rare diseases, infectious diseases, and drug repurposing. Highlights: Shared ambition to accelerate drug discovery by…
Leiden University Medical Center (LUMC) has successfully implemented artificial intelligence (AI) to optimize radiotherapy planning for patients with head and neck cancer. This has led to significant time savings and improved protection of healthy tissues during treatment. Traditionally, creating a…
Leiden Bio Science Park joined CDMO Live 2025 in Rotterdam, highlighting the Netherlands’ growing role as a European biotech leader. From expert panels to a behind-the-scenes tour at HALIX, the event showcases how innovation and collaboration thrive in our ecosystem.
Leiden Bio Science Park was proud to welcome Minister Fleur Agema for a visit organized by the Vereniging Innovatieve Geneesmiddelen. The tour highlighted how research, industry, and education come together in a unique ecosystem that powers life sciences innovation in…
Astellas Pharma has initiated a global campaign to address the critical issue of delayed bladder cancer diagnoses. In collaboration with the World Bladder Cancer Patient Coalition (WBCPC) and behavioral scientists, the company aims to understand the barriers preventing individuals from…
Pioneering research at Leiden Faculty of Science awarded NWO grants Three bold ideas, one shared goal: advancing science for a better future From smarter drug delivery to cosmic mysteries and innovative solar energy storage, three researchers from Leiden University’s Faculty…
From therapeutic mini proteins to pharma compliance services, international life sciences companies are choosing Leiden as the place to grow. Among them are VRG Therapeutics (Hungary) and CONVAL Group (Turkey) — two companies that recently established operations at the Leiden…
The Biotech Training Facility at Leiden Bio Science Park welcomed the Merck on Tour mobile lab, a travelling showcase of the latest life science innovations. Throughout the day, visitors had the chance to explore new technologies up close, engage in…
MIMETAS, a leading organ-on-a-chip company, has announced the publication of a new peer-reviewed study that marks a major advance in cardiovascular disease research. The study, titled “Microfluidic artery-on-a-chip model with unidirectional gravity-driven flow for high-throughput applications”, presents a novel 3D…